DRUG · COUNSELLING NOTES
Mannitol
Osmitrol, OSMITROL INJECTION 10%
Updated
New prescription
indication: _____. IV by HCP; report breathlessness, swelling; warned on allergies; serious/common AEs: headache, nausea, thirst; electrolyte imbalance; non-pharm: monitor fluid intake, urine output.
Refill prescription
refilled, adherence discussed, no SEs were reported
Dose change
Dose change discussed. new dose reviewed; IV by HCP; report breathlessness, swelling; warned on allergies; serious/common AEs: headache, nausea, thirst; electrolyte imbalance; non-pharm: monitor fluid intake, urine output.